AIxCrypto Holdings, Inc.

AIXC
$1.10 (- $0.12 - 9.84%)
Last updated: 2026-07-06 10:18 UTC
AIXC Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorTechnology
IndustrySoftware - Infrastructure
ISINUS74754R3012
CUSIP74754R301
Market Price1.1
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E Ratio0.95
EPS2.85
Market Cap$14.0M
Book Value0.8
Price to Book3.388
Beta0.28
52w High8.81
52w Low1.61
Next Earnings DateN/A

AIxCrypto Holdings, Inc. trades under ticker AIXC on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Technology exposure. Identifiers: ISIN US74754R3012, CUSIP 74754R301.

About the Company
AIxCrypto Holdings, Inc., a clinical-stage therapeutics company, focuses on the development of treatments for adult and pediatric cancer. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase I clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. The company was formerly known as Qualigen Therapeutics, Inc. and changed its name to AIxCrypto Holdings, Inc. in November 2025. The company was founded in 1996 and is based in Carlsbad, California.
Price History